These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30635607)

  • 1. Computational insights into the role of α-strand/sheet in aggregation of α-synuclein.
    Balupuri A; Choi KE; Kang NS
    Sci Rep; 2019 Jan; 9(1):59. PubMed ID: 30635607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a partially folded intermediate in alpha-synuclein fibril formation.
    Uversky VN; Li J; Fink AL
    J Biol Chem; 2001 Apr; 276(14):10737-44. PubMed ID: 11152691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.
    Uversky VN; Eliezer D
    Curr Protein Pept Sci; 2009 Oct; 10(5):483-99. PubMed ID: 19538146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (De)stabilization of Alpha-Synuclein Fibrillary Aggregation by Charged and Uncharged Surfactants.
    Loureiro JA; Andrade S; Goderis L; Gomez-Gutierrez R; Soto C; Morales R; Pereira MC
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Α-synuclein misfolding and Parkinson's disease.
    Breydo L; Wu JW; Uversky VN
    Biochim Biophys Acta; 2012 Feb; 1822(2):261-85. PubMed ID: 22024360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Capped Peptide of the Aggregation Prone NAC 71-82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations.
    Näsström T; Ådén J; Shibata F; Andersson PO; Karlsson BCG
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J; Uversky VN; Fink AL
    Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT; Du HN; Tang L; Hu J; Hu HY
    Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-Type
    Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
    Front Mol Biosci; 2022; 9():910104. PubMed ID: 35836937
    [No Abstract]   [Full Text] [Related]  

  • 11. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Insights into the Misfolding and Dimerization Dynamics of the Full-Length α-Synuclein from Atomistic Discrete Molecular Dynamics Simulations.
    Zhang Y; Wang Y; Liu Y; Wei G; Ding F; Sun Y
    ACS Chem Neurosci; 2022 Nov; 13(21):3126-3137. PubMed ID: 36278939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
    El-Agnaf OM; Irvine GB
    J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perturbation in Long-Range Contacts Modulates the Kinetics of Amyloid Formation in α-Synuclein Familial Mutants.
    Ranjan P; Kumar A
    ACS Chem Neurosci; 2017 Oct; 8(10):2235-2246. PubMed ID: 28759722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the acidic domain of α-synuclein in amyloid fibril formation: a molecular dynamics study.
    Park S; Yoon J; Jang S; Lee K; Shin S
    J Biomol Struct Dyn; 2016; 34(2):376-83. PubMed ID: 25869255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crocin Inhibits the Fibrillation of Human α-synuclein and Disassembles Mature Fibrils: Experimental Findings and Mechanistic Insights from Molecular Dynamics Simulation.
    Saffari B; Amininasab M
    ACS Chem Neurosci; 2021 Nov; 12(21):4037-4057. PubMed ID: 34636232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of oligomers during alpha-synuclein aggregation using intrinsic tryptophan fluorescence.
    Dusa A; Kaylor J; Edridge S; Bodner N; Hong DP; Fink AL
    Biochemistry; 2006 Feb; 45(8):2752-60. PubMed ID: 16489768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
    Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
    Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein.
    Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS
    Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.